Charles Chapron

No ORCID on file · 365 papers in corpus · active 1990-2026

Study types

  • article 241
  • review 54
  • other 40
  • book-chapter 18
  • letter 7

Condition tags

  • endometriosis 297
  • die_deep_infiltrating 76
  • infertility 67
  • endometrioma 49
  • adenomyosis 41
  • dysmenorrhea 36
  • chronic_pelvic_pain 33
  • dyspareunia 25
  • bladder_endometriosis 12
  • bowel_endometriosis 2
article 2024
BMC medicine ·doi:10.1186/s12916-024-03738-9

BACKGROUND: Endometriosis, affecting 10% of women in their reproductive years, remains poorly understood. Both individual and environmental unexplained factors are implicated in this heterogenous condition. This study aims to examine the in…

article 2023
European journal of radiology ·doi:10.1016/j.ejrad.2023.110730

OBJECTIVE: To compare computed tomography-enterography (CTE) and magnetic resonance-enterography (MRE) in the detection of right-sided bowel deep infiltrating endometriosis (DIE). MATERIALS AND METHODS: Fifty women with DIE who underwent p…

other 2023
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2023.01.009

RESEARCH QUESTION: Is a decrease in dysmenorrhoea after suppressive hormonal therapy a marker of the endometriosis phenotype and of greater disease severity? DESIGN: Retrospective observational cohort study conducted in a French university…

article 2023
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-023-01341-6

Endometriosis is a condition characterized by increased oxidative stress and chronic inflammation, which can be treated with progestins and other progesterone receptor ligands. However, some patients are refractory to this treatment and the…

book-chapter 2023
·doi:10.1016/b978-2-294-77656-4.00029-1
article 2023
Human Reproduction ·doi:10.1093/humrep/dead252

STUDY QUESTION: Do severe endometriosis-related painful symptoms impact ART live birth rates? SUMMARY ANSWER: Severe pain symptoms are not associated with reduced ART live birth rates in endometriosis patients. WHAT IS KNOWN ALREADY: ART …

article 2023
·doi:10.1684/mte.2023.0951
rct 2023
Drugs in R&D ·doi:10.1007/s40268-023-00427-5

INTRODUCTION: BAY1128688 is a selective inhibitor of aldo-keto reductase family 1 member C3 (AKR1C3), an enzyme implicated in the pathology of endometriosis and other disorders. In vivo animal studies suggested a potential therapeutic appli…

article 2023
·doi:10.1016/j.jeud.2023.100031

Consequences of the shift from the use of non-invasive testing for diagnosis to screening purposes • As the high-throughput screening and sequencing become increasingly faster and affordable, that there will be a swell of commercial non-inv…

article 2023
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2023.102708

OBJECTIVE: To investigate the medical journey and the quality of life of French endometriosis-affected women, from the onset of the symptoms to the therapeutic management. STUDY DESIGN: Between January 15th 2020 and February 3rd 2020, a pr…

article 2023
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-023-01173-4

In order to inform patients undergoing ART regarding their chances for motherhood, it seems useful to describe "freeze all" outcomes according to the different potential indications. The goal of this study was to examine the impact of a "fr…

article 2023
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2023.02.008

RESEARCH QUESTION: Is there a change in magnetic resonance imaging (MRI) criteria of diffuse and focal phenotypes of adenomyosis before and after pregnancy? DESIGN: A retrospective, monocentric, observational study in a single academic ter…

other 2023
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2023.05.008

RESEARCH QUESTION: What are the reproductive outcomes and the prognostic factors of live birth rates in patients with endometriosis referred to oocyte donation after multiple IVF failures? DESIGN: Observational cohort study including all w…

article 2023
·doi:10.1093/humrep/dead093.687

Abstract Study question What are the reproductive outcomes and the prognostic factors of live birth rates in endometriosis patients referred to oocyte donation after multiple in vitro fertilization(IVF)-failures? Summary answer In this spec…

book-chapter 2023
·doi:10.1016/b978-2-294-78134-6.00006-1
article 2023
Fertility and sterility ·doi:10.1016/j.fertnstert.2023.11.039

OBJECTIVE: To compare assisted reproductive technologies (ARTs) outcomes between fresh vs. freeze-all strategies in infertile women affected by adenomyosis. DESIGN: A single-center observational study. SETTINGS: University hospital-based …

article 2023
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2023.102664

The French National College of Obstetricians and Gynecologists (CNGOF) published guidelines for managing endometriosis-associated pain in 2018. Given the development of new pharmacological therapies and a review that was published in 2021, …

article 2023
·doi:10.1016/j.jeud.2023.100050

To determine whether recurrent endometriomas are associated with multiple deep infiltrating endometriosis (DIE) lesions. This was an observational, cross-sectional, cohort study of 611 consecutive symptomatic women with endometrioma who und…

article 2022
Fertility and sterility ·doi:10.1016/j.fertnstert.2022.12.039

OBJECTIVE: To evaluate the prevalence on magnetic resonance imaging (MRI) of ovarian endometrioma (OMA) and deep infiltrating endometriosis (DIE) in adolescents presenting with severe dysmenorrhea. DESIGN: Prospective study. SETTING: Clin…

article 2022
EClinicalMedicine ·doi:10.1016/j.eclinm.2021.101263

BACKGROUND: The time between symptoms onset and endometriosis diagnosis is usually long. The negative impacts of delayed endometriosis diagnosis can affect patients and health outcomes. METHODS: We conducted a case-control study using clini…

article 2022
JAMA network open ·doi:10.1001/jamanetworkopen.2021.47788

Importance: Endometriosis is an inflammatory disease with a heterogeneous presentation that affects women of childbearing age. Given the limitations of previous retrospective studies, it is still unclear whether endometriosis has adverse im…

review 2022
Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare10122515

This work provides consensus guidance regarding clinical diagnosis and early medical management of endometriosis within Asia. Clinicians with expertise in endometriosis critically evaluated available evidence on clinical diagnosis and early…

article 2022
Human Reproduction ·doi:10.1093/humrep/deac166

STUDY QUESTION: What outcomes should be reported in all studies investigating uterus-sparing interventions for treating uterine adenomyosis? SUMMARY ANSWER: We identified 24 specific and 26 generic core outcomes in nine domains. WHAT IS K…

article 2022
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2022.08.097

RESEARCH QUESTION: Does endometrioma size affect the number of oocytes retrieved after ovarian stimulation in women with endometriosis-related infertility undergoing IVF/intracytoplasmic sperm injection (ICSI)? DESIGN: Cohort study of infe…

article 2022
·doi:10.1093/humrep/deac107.350

Abstract Study question Are there any fertility disorders and related local and/or systemic immune changes during the early implantation period in a mouse model of adenomyosis? Summary answer An increase in fertility disorders was observed …